Herbalife begins 2026 with 22.8% jump in first-quarter profit

Herbalife Ltd. reported Wednesday a 22.8% jump in first-quarter net income with upticks in Asia-Pacific and Latin America sales offsetting a decline in North America.

The nutritional supplement manufacturer has its East Coast manufacturing hub in Winston-Salem with at least 750 employees.

Diluted earnings were 57 cents a share, while adjusted earnings were 64 cents.

There was an earnings projection of 55 cents by two analysts surveyed by Zacks Investment Research. Analysts typically exclude one-time gains and charges from their forecasts.

Overall sales were up 7.8% to $1.3 billion.

Herbalife's first-quarter financial guidance was net sales in a range of up 3% to 7%, or $1.26 billion to 1.31 billion.

Asia-Pacific sales that exclude China climbed 17.3% to $495.8 million, primarily from increased sales in India. Latin American sales jumped 17.1% to $242 million.

Meanwhile, North American sales declined 2.7% to $247.6 million.

"We delivered strong first-quarter results that exceeded guidance, and we successfully completed our debt refinancing," Herbalife chief executive Stephan Gratziani said.

Herbalife completed on April 30 the refinancing of $1.45 billion in senior secured debt.

"We took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation."

Herbalife closed April 30 on its $55 million purchase of Bioniq's core personalized nutrition business, of which $10 million was paid before closing and the remaining $45 million over five years.

The agreement also provides for up to $95 million in contingent payments based on certain future Bioniq product sales performance.

Herbalife also obtained a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides. The option expires on Dec. 31, 2031.

"Personalization has long been foundational to Herbalife's business, and our history is defined by innovation, a forward-looking mindset and a willingness to evolve alongside consumer needs," Gratziani said.

"Our recent acquisitions of Pro2col, Link BioSciences, Pruvit and Bioniq expand our personalization ecosystem, enabling an enhanced and differentiated experience for both customers and distributors and accelerating our evolution into the world's premier health and wellness company, community and platform."

Its initial fiscal 2026 guidance is net sales in a range of up 1% to 6%, or from $5.08 billion to $5.33 billion.

The guidance was updated Wednesday to a range of up 1.5% to 5.5%.

The second-quarter guidance is for net sales to increase also in a range of 1.5% to 5.5%.

Copyright 2026 Tribune Content Agency. All Rights Reserved.

This story was originally published May 8, 2026 at 4:15 AM.